Burden of Diabetes and Prediabetes in Nepal: A Systematic Review and Meta-Analysis.

Diabetes Meta-analysis Nepal Prevalence Systematic review

Journal

Diabetes therapy : research, treatment and education of diabetes and related disorders
ISSN: 1869-6953
Titre abrégé: Diabetes Ther
Pays: United States
ID NLM: 101539025

Informations de publication

Date de publication:
Sep 2020
Historique:
received: 29 04 2020
pubmed: 28 7 2020
medline: 28 7 2020
entrez: 27 7 2020
Statut: ppublish

Résumé

Unhealthy behaviors, such as energy-dense food choices and a sedentary lifestyle, both of which are established risk factors for diabetes, are common and increasing among Nepalese adults. Previous studies have reported a wide variation in the prevalence of prediabetes and diabetes in Nepal, and thus a more reliable pooled estimate is needed. Furthermore, Nepal underwent federalization in 2015, and the province-specific prevalence, which is necessary for the de novo provincial government to formulate local health policies, is lacking. This study aims to provide a comprehensive summary of the current literature on various aspects of diabetes in Nepal, i.e., the prevalence of prediabetes and diabetes as well as of the awareness, treatment, and control of diabetes in Nepal. This review was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. We searched three electronic databases-PubMed, Scopus, and Web of Science-using a comprehensive search strategy to identify eligible studies published up to April 2, 2020. Data on prevalence estimates of prediabetes and diabetes were extracted and pooled in a meta-analysis using a random effect model. Subgroup analyses and meta-regression were conducted to assess heterogeneity across the studies. The quality of included studies was assessed using the New Castle-Ottawa scale. We included 14 eligible studies that comprised a total of 44,129 participants and 3517 diabetes cases. Half of the included studies had good quality. Overall, the prevalence of prediabetes and diabetes was 9.2% (95% CI 6.6-12.6%) and 8.5% (95% CI 6.9-10.4%), respectively. Among the participants with diabetes, only 52.7% (95% CI 41.7-63.4%) were aware of their diabetes status, and 45.3% (95% CI 31.6-59.8%) were taking antidiabetic medications. Nearly one-third of those under antidiabetic treatment (36.7%; 95% CI 21.3-53.3%) had their blood glucose under control. The prevalence of prediabetes and diabetes gradually increased with increasing age and was more prevalent among males and urban residents. There was a wide variation in diabetes prevalence across the provinces in Nepal, the lowest 2% in Province 6 to the highest 10% in Province 3 and Province 4. The prevalence of prediabetes and diabetes was high in Nepal, while its awareness, treatment, and control were low. Our findings call for urgent nationwide public health action in Nepal.

Sections du résumé

BACKGROUND BACKGROUND
Unhealthy behaviors, such as energy-dense food choices and a sedentary lifestyle, both of which are established risk factors for diabetes, are common and increasing among Nepalese adults. Previous studies have reported a wide variation in the prevalence of prediabetes and diabetes in Nepal, and thus a more reliable pooled estimate is needed. Furthermore, Nepal underwent federalization in 2015, and the province-specific prevalence, which is necessary for the de novo provincial government to formulate local health policies, is lacking. This study aims to provide a comprehensive summary of the current literature on various aspects of diabetes in Nepal, i.e., the prevalence of prediabetes and diabetes as well as of the awareness, treatment, and control of diabetes in Nepal.
METHODS METHODS
This review was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. We searched three electronic databases-PubMed, Scopus, and Web of Science-using a comprehensive search strategy to identify eligible studies published up to April 2, 2020. Data on prevalence estimates of prediabetes and diabetes were extracted and pooled in a meta-analysis using a random effect model. Subgroup analyses and meta-regression were conducted to assess heterogeneity across the studies. The quality of included studies was assessed using the New Castle-Ottawa scale.
RESULTS RESULTS
We included 14 eligible studies that comprised a total of 44,129 participants and 3517 diabetes cases. Half of the included studies had good quality. Overall, the prevalence of prediabetes and diabetes was 9.2% (95% CI 6.6-12.6%) and 8.5% (95% CI 6.9-10.4%), respectively. Among the participants with diabetes, only 52.7% (95% CI 41.7-63.4%) were aware of their diabetes status, and 45.3% (95% CI 31.6-59.8%) were taking antidiabetic medications. Nearly one-third of those under antidiabetic treatment (36.7%; 95% CI 21.3-53.3%) had their blood glucose under control. The prevalence of prediabetes and diabetes gradually increased with increasing age and was more prevalent among males and urban residents. There was a wide variation in diabetes prevalence across the provinces in Nepal, the lowest 2% in Province 6 to the highest 10% in Province 3 and Province 4.
CONCLUSIONS CONCLUSIONS
The prevalence of prediabetes and diabetes was high in Nepal, while its awareness, treatment, and control were low. Our findings call for urgent nationwide public health action in Nepal.

Identifiants

pubmed: 32712902
doi: 10.1007/s13300-020-00884-0
pii: 10.1007/s13300-020-00884-0
pmc: PMC7434818
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

1935-1946

Références

Sci Rep. 2018 Oct 9;8(1):14995
pubmed: 30301902
Glob Health Action. 2016 Oct 18;9:31704
pubmed: 27760677
Int J Hypertens. 2011;2011:821971
pubmed: 21629873
PLoS Med. 2009 Jul 21;6(7):e1000097
pubmed: 19621072
Diabet Med. 2006 Oct;23(10):1130-5
pubmed: 16978379
Southeast Asian J Trop Med Public Health. 2000 Mar;31(1):163-6
pubmed: 11023087
J Diabetes Investig. 2020 Jan;11(1):241-249
pubmed: 31172682
Glob Health Action. 2015 Nov 26;8:29088
pubmed: 26613684
Asia Pac J Public Health. 2008;20(2):159-69
pubmed: 19124310
Asia Pac J Clin Nutr. 2017 Mar;26(2):358-367
pubmed: 28244717
Lancet. 2015 Aug 22;386(9995):743-800
pubmed: 26063472
Lancet Diabetes Endocrinol. 2018 Dec;6(12):966-978
pubmed: 30287102
Nepal Med Coll J. 2007 Sep;9(3):154-6
pubmed: 18092429
Lancet. 1998 Sep 12;352(9131):837-53
pubmed: 9742976
PLoS One. 2018 Nov 2;13(11):e0206491
pubmed: 30388140
Lancet. 2006 Nov 11;368(9548):1651-9
pubmed: 17098083
Lancet Diabetes Endocrinol. 2016 Dec;4(12):979-980
pubmed: 27825647
BMC Public Health. 2012 May 25;12:380
pubmed: 22630043
Southeast Asian J Trop Med Public Health. 2011 Jan;42(1):197-207
pubmed: 21323183
Singapore Med J. 2000 Jun;41(6):264-7
pubmed: 11109341
PLoS One. 2018 Jun 1;13(6):e0198343
pubmed: 29856828
Lancet. 2016 Oct 8;388(10053):1659-1724
pubmed: 27733284
Diabet Med. 2003 Feb;20(2):170-1
pubmed: 12581274
Diabetes Care. 2000 Apr;23 Suppl 2:B5-10
pubmed: 10860184
Sci Rep. 2019 Oct 25;9(1):15382
pubmed: 31653888
Nat Med. 2019 Nov;25(11):1667-1679
pubmed: 31700182
Diabetes Care. 2012 Mar;35(3):556-64
pubmed: 22301125
PLoS One. 2015 Aug 05;10(8):e0134834
pubmed: 26244512
Prev Nutr Food Sci. 2019 Sep;24(3):235-244
pubmed: 31608248
Diabetes Care. 2010 Jan;33 Suppl 1:S62-9
pubmed: 20042775
Lancet Glob Health. 2018 Dec;6(12):e1352-e1362
pubmed: 30219315
Diabetes Res Clin Pract. 2005 Feb;67(2):167-74
pubmed: 15649577
J Hum Hypertens. 2019 Aug;33(8):613-625
pubmed: 30659279
Lancet. 2012 Jun 16;379(9833):2279-90
pubmed: 22683128
JNMA J Nepal Med Assoc. 2013 Jan-Mar;52(189):205-12
pubmed: 23591297
BMC Public Health. 2018 May 31;18(1):677
pubmed: 29855293
Diabetes Care. 2006 Jan;29 Suppl 1:S43-8
pubmed: 16373932
Hum Biol. 1992 Dec;64(6):807-19
pubmed: 1427740
J Glob Health. 2019 Dec;9(2):020301
pubmed: 31448112
Diabetes Res Clin Pract. 2018 Jun;140:271-278
pubmed: 29626582
PLoS One. 2017 Sep 6;12(9):e0183953
pubmed: 28877254
Sci Rep. 2016 Aug 11;6:31426
pubmed: 27510966
Indian Heart J. 2018 Dec;70 Suppl 3:S20-S27
pubmed: 30595258
BMC Public Health. 2019 Jan 31;19(1):140
pubmed: 30704495

Auteurs

Nipun Shrestha (N)

Institute for Health and Sport (IHeS), Victoria University, Melbourne, Australia.

Shiva Raj Mishra (SR)

Nepal Development Society, Chitwan, Nepal. shivarajmishra@gmail.com.

Saruna Ghimire (S)

Department of Sociology and Gerontology and Scripps Gerontology Center, Miami University, Oxford, OH, USA.

Bishal Gyawali (B)

Section of Global Health, Department of Public Health, University of Copenhagen, Copenhagen, Denmark.

Suresh Mehata (S)

Ministry of Health and Population, Government of Nepal, Kathmandu, Nepal.

Classifications MeSH